Low-Dose Oral Minoxidil during Chemotherapy: A Review of the Mechanism and Current Evidence

dc.contributor.authorKearney, Caitlin A.
dc.contributor.authorGordon, Allison
dc.contributor.authorMarkova, Alina
dc.contributor.authorFreites Martínez, Azael David
dc.contributor.authorTattersall, Ian W.
dc.contributor.authorShapiro, Jerry
dc.contributor.authorLacouture, Mario
dc.contributor.authorSicco, Kristen I. Lo
dc.date.accessioned2025-12-05T09:57:23Z
dc.date.available2025-12-05T09:57:23Z
dc.date.issued2025
dc.description.abstractChemotherapy-induced alopecia (CIA) significantly impacts patients’ quality of life. While low-dose oral minoxidil (LDOM) shows promise in treating CIA after chemotherapy completion, its safety and efficacy when given during active chemotherapy remain unclear. This review examined existing literature on CIA pathogenesis, minoxidil’s mechanism of action, and LDOM efficacy to explore its potential use during chemotherapy.
dc.description.filiationUEMspa
dc.description.impact1.3 Q3 JCR 2024spa
dc.description.impact0.460 Q2 SJR 2024spa
dc.description.impactNo data IDR 2024spa
dc.description.sponsorshipSin financiación
dc.identifier.citationKearney, C. A., Gordon, A., Markova, A., Freites-Martinez, A., Tattersall, I. W., Shapiro, J., Lacouture, M. E., & Lo Sicco, K. I. (2025). Low-dose oral minoxidil during chemotherapy: A review of the mechanism and current evidence. Skin Appendage Disorders, 1-9. https://doi.org/10.1159/000548112
dc.identifier.doi10.1159/000548112
dc.identifier.issn2296-9195
dc.identifier.issn2296-9160
dc.identifier.urihttps://hdl.handle.net/11268/16572
dc.language.isoeng
dc.peerreviewedSi
dc.relation.publisherversionhttps://doi.org/10.1159/000548112
dc.rightsAttribution-NonCommercial 4.0 Internationalen
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.subject.otherAlopecia
dc.subject.otherQuimioterapia
dc.subject.otherMinoxidil
dc.subject.sdgGoal 3: Ensure healthy lives and promote well-being for all at all ages
dc.subject.unescoEnfermedad de la piel
dc.subject.unescoCáncer
dc.subject.unescoTratamiento médico
dc.titleLow-Dose Oral Minoxidil during Chemotherapy: A Review of the Mechanism and Current Evidence
dc.typejournal article
dc.type.hasVersionVoR
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Low-Dose Oral Minoxidil during Chemotherapy_2025.pdf
Size:
737.89 KB
Format:
Adobe Portable Document Format